HCA - HCA Healthcare, Inc.
B. Metzler seel. Sohn and Co. AG bought a new position in HCA Healthcare, Inc. (NYSE: HCA) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 10,563 shares of the company's stock, valued at approximately $4,118,000. Other hedge funds also recently bought
Advisors Capital Management LLC acquired a new stake in shares of HCA Healthcare, Inc. (NYSE: HCA) in the undefined quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 6,507 shares of the company's stock, valued at approximately $2,537,000. Several other institutional investors have also added
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences: September 9, 2026, at 10:15am ET at the Wells Fargo Healthcare Conference September 15, 2026, at 1:50pm CT at the Jefferies Healthcare Conference A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and tim.
BlackRock Inc. acquired a new stake in shares of HCA Healthcare, Inc. (NYSE: HCA) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 13,003,600 shares of the company's stock, valued at approximately $5,069,974,000. BlackRock Inc. owned approximately 6.01% of HCA Healthcare at the
On August 18, 2026, we conducted a discounted cash flow (DCF) analysis for HCA Healthcare Inc (HCA) in light of its recent price performance. The stock has expe
Assenagon Asset Management S.A. lessened its holdings in HCA Healthcare, Inc. (NYSE: HCA) by 81.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,001 shares of the company's stock after selling 63,779 shares during the period. Assenagon
Deane Retirement Strategies Inc. acquired a new stake in shares of HCA Healthcare, Inc. (NYSE: HCA) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 12,298 shares of the company's stock, valued at approximately $4,796,000. HCA Healthcare comprises 2.0%
NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare's East Florida Division, has been appointed president of HCA Healthcare's new Ambulatory Operations Group. Dr. Schlosser will succeed Dr. Michael Cuffe, who a.
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Fortinet, Inc. (NASDAQ:FTNT) is good and he likes it. “They're doing a good job,” he added.
If you purchased or acquired stock in HCA and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at [email protected] or by telephone at (212) 355-4648.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The law firm of [url="]Kirby McInerney LLP[/url] reminds investors of its investigation on behalf of HCA Healthcare, Inc. (âHCA Healthcareâ or the âCompan
NEW YORK--(BUSINESS WIRE)---- $HCA #classaction--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of HCA Healthcare, Inc. (“HCA Healthcare” or the “Company”) (NYSE: HCA) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE INVESTIGATION]What Happened?On July 14, 2026, HCA Healthcare issued a press release reporting its preliminary financial and operat.
NEW YORK, July 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc.("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
U.S. Fund A Shares (without sales charge) posted a return of -0.04% in second quarter of 2026. Leading contributors in the First Eagle U.S. Fund this quarter included Alphabet Inc. Class C, Texas Instruments, Elevance Health, Bank of New York Mellon Corporation and Cummins. The leading detractors in the quarter were First Eagle Global Real Assets Cayman Fund Ltd. USD, HCA Healthcare, Charter Communications, Inc. Class A, Exxon Mobil and Salesforce.
HCA Healthcare Inc. (NYSE:HCA) on Friday posted upbeat second-quarter earnings.
HCA Healthcare (NYSE: HCA) said its second-quarter performance reflected solid demand in several service lines and 11% growth in diluted earnings per share, but the company faced increased financial pressure as patients losing health insurance exchange coverage shifted largely into the uninsured population. Chief Executive Officer Sam Hazen said the expiration of enhanced premium tax credits
Diluted Earnings Per Share Growth: 11% in the quarter and year-to-date.Admissions Growth: Increased 2.5% in the second quarter.Equivalent Admissions Growth: In